Skip to content

The Effect of Motivational Interviewing on patients with Type 2 Diabetes

The Effect of Motivational Interviewing on the Self-efficacy in Management of diabetes and laboratory outcomes in patients with Type 2 Diabetes referring to Bukan diabetes association in 2016

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20131112015390N3
Enrollment
60
Registered
2020-07-22
Start date
2016-12-10
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: First, the intervention group was divided into 3 small groups of 10 patients.The content of motivational interview sessions was designed in 5 areas (nutrition, phys
session 2: Emotional recognition exercises, exercise and completion of impact dimensions with emotional dimension and homework assignments
session3: Brain storming exercise, short-term and long-term benefits and losses, and description and practice of corrective and alternative options
session 4: Defining values, performing practices to identify and prioritize first-class values, practicing the definition of values, and practicing value-behavior matching
session 5: Summary and previous session practices in the form of practicing the vision, and preparation to initiate the behavioral change program. Four weeks after the intervention finished, all the p

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Willing to participate in the study No history of psychological disorders such as depression based on the patients' records. Ability to read and write No previous participation in similar programs of motivational interview No communication problems such as blindness and deafness and any cognitive impairment

Exclusion criteria

Exclusion criteria: Not willing to continue participation in the study

Design outcomes

Primary

MeasureTime frame
Blood sugar. Timepoint: In the begining of the study and 14 days after intervention fininshed. Method of measurement: Blood test.;Glycosylated hemoglobin. Timepoint: In the begining of the study and 14 days after intervention fininshed. Method of measurement: Blood test.;Cholesterol. Timepoint: In the begining of the study and 14 days after intervention fininshed. Method of measurement: Blood test.;Triglycerides. Timepoint: In the begining of the study and 14 days after intervention fininshed. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Qahremani

Oroumia University of Medical Sciences

Gahramania6@gmail.com0098 44 332754961

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026